In development: Guidance, quality standards and advice
Showing 391 to 392 of 392
| Title | Type | Expected publication date |
|---|---|---|
| Zolbetuximab with chemotherapy for untreated claudin 18.2-positive HER2 negative unresectable advanced gastric or gastro-oesophageal junction adenocarcinoma [ID5123] | Technology appraisal guidance | TBC |
| Zuranolone for treating postnatal depression [ID6431] | Technology appraisal guidance |